Mangoceuticals shares surge 31.42% intraday after announcing $2.5M capital raise via registered direct and private placements.

Mangoceuticals, Inc. surged 31.42% intraday following the announcement of a $2.5 million registered direct offering and private placement with institutional investors. The transaction, closed on December 19, 2025, involved 1,930,502 units priced at $1.295 each, with proceeds intended for general corporate purposes and working capital. The funding, executed at market price under Nasdaq rules, likely boosted investor confidence in the company’s operational flexibility and growth prospects, particularly in its telemedicine-driven men’s wellness services. The move aligns with the stock’s intraday rally, reflecting positive market reception to the capital infusion.